The document discusses how to make data more impactful for organizations. It outlines some of the challenges that prevent effective use of data, including slow response times to questions. The author proposes a user-centric business intelligence approach where non-technical users can directly explore and analyze data through intuitive tools, rather than relying on IT and data professionals. Complex queries can still be handled through SQL but the goal is to encode business logic in a way that streamlines analysis for a variety of users and their questions.
The document discusses how to make data more impactful for organizations. It outlines some of the challenges that prevent effective use of data, including slow response times to questions. The author proposes a user-centric business intelligence approach where non-technical users can directly explore and analyze data through intuitive tools, rather than relying on IT and data professionals. Complex queries can still be handled through SQL but the goal is to encode business logic in a way that streamlines analysis for a variety of users and their questions.
The document provides an introduction to machine/statistical learning. It outlines the talk which aims to provide a sufficient basis for applied predictive modeling rather than developing a robust understanding of ML algorithms. The preliminary outline covers model purpose, the basic study design of ML including model representation, classification vs regression problems, and supervised vs unsupervised learning. It also discusses model assessment and selection including the interplay between bias, variance and complexity, and cross-validation. The last point is on the single algorithm hypothesis and deep learning.
This document provides information on the use of novel oral anticoagulants (NOACs) for atrial fibrillation (AFib)-related stroke prevention. It notes that Asians have higher risks of transient ischemic attack (TIA) and cerebrovascular accident (CVA) with AFib than other groups. While aspirin is no better than placebo, NOACs have rapid onset, short half-lives, and fixed dosing without monitoring. The four main NOACs are dabigatran (Pradaxa), rivaroxaban (Xarelto), apixaban (Eliquis), and edoxaban (Lixiana). Special considerations include higher renal excretion of P
The document discusses project management methods and focuses on three key areas: scope, cost and time, and people. It provides an overview of work breakdown structures, critical paths, Gantt charts, and earned value management as tools to help plan, organize and control projects. It also emphasizes the importance of communication, defining roles and responsibilities, and balancing logic, emotion and intuition when working with people on projects. The overall goal is to make project management deployment possible for a variety of projects.
